Welcome to our dedicated page for LOGICMARK SEC filings (Ticker: LGMK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
LogicMark’s SEC disclosures weave together medical-device regulation, IoT R&D, and government contract accounting—details buried in hundreds of pages that few have time to untangle. If you’ve ever asked, “Where can I find LogicMark insider trading Form 4 transactions or a plain-English view of the latest quarterly earnings report 10-Q filing?”, you’re in the right place.
Stock Titan’s AI-powered analysis turns LogicMark SEC filings into quick insights. Our engine delivers real-time alerts the moment a Form 4 posts, so LogicMark Form 4 insider transactions appear on your screen before the market notices. Need the revenue breakout between Veterans Health Administration sales and direct-to-consumer channels? The annual report 10-K simplified view highlights it. Looking for supply-chain risk factors or new Connected Care Platform patents? Our summaries point you to the exact paragraph—no scrolling required.
Every submission—10-K, 10-Q, 8-K material events explained, S-1 capital raises, proxy statement executive compensation data, and more—sits in one place with AI context. Use it to:
- Track LogicMark earnings report filing analysis quarter over quarter
- Monitor executive stock transactions Form 4 in real time
- Understand LogicMark SEC documents with AI before making a trade
LogicMark (LGMK) reported a director equity grant. On 10/09/2025, director Robert A. Curtis was awarded options to purchase 3,125,000 shares of common stock at an exercise price of $0.0032 per share. The options are listed as exercisable on 10/09/2025 and expire on 10/08/2035. Following the transaction, 3,125,000 derivative securities were beneficially owned, held directly. The filing states the options were received as compensation for board service for the quarter ended September 30, 2025.
LogicMark (LGMK) reported an insider equity award. A company director received options to purchase 3,125,000 shares of common stock on 10/09/2025 at an exercise price of $0.0032 per share (Transaction Code: A).
The options are exercisable from 10/09/2025 and expire on 10/08/2035. Following the grant, the reporting person beneficially owns 3,125,000 derivative securities, held directly. The filing notes the options were received as compensation for board service for the quarter ended September 30, 2025.
LogicMark, Inc. (LGMK) reported a director equity grant on a Form 4. On 10/09/2025, a board member received options to purchase 3,125,000 shares of common stock at an exercise price of $0.0032 per share. The options are exercisable on 10/09/2025 and expire on 10/08/2035.
The filing states the options were granted as compensation for services as a member of the board of directors for the quarter ended September 30, 2025. Following the reported transaction, the reporting person beneficially owns 3,125,000 derivative securities, held directly.
FAQ
What is the current stock price of LOGICMARK (LGMK)?
What is the market cap of LOGICMARK (LGMK)?
